IP Library Granted Patent US 10,945,630
Granted Patent B2
US 10,945,630 · App. 14/466,160 · Granted Mar 16, 2021

Use of Electrochemical Impedance Spectroscopy (EIS) in gross failure analysis

Inventors: Andrea Varsavsky (Santa Monica, CA); Fei Yu (Chatsowrth, CA); Ning Yang (New York, NY)
Assignee: MEDTRONIC MINIMED, INC.
A61B5/0537A61B5/0538A61B5/1468A61B5/1473A61B5/1495A61B5/14532A61B5/14865A61B5/7221A61B5/7246A61M5/1582G01N27/026A61B5/6849A61M5/14244A61M5/14276A61M2005/1726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,945,630
App. No.
14/466,160
Granted
Mar 16, 2021
Kind
B2
Abstract

Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.

Claims (33)

1. A method of performing diagnostics on a subcutaneous or implanted glucose sensor having at least one working electrode, comprising:

defining a vector containing values associated with one or more electrochemical impedance spectroscopy (EIS)-based parameters and values associated with one or more non-EIS-based parameters;

defining a combined threshold value for a combination of said EIS-based parameters and said non-EIS-based parameters;

performing, by a microprocessor, a first EIS procedure to generate a first set of data for said values associated with the one or more EIS-based parameters;

after a calculated time interval, performing, by said microprocessor, a second EIS procedure to generate a second set of data for said values associated with the one or more EIS-based parameters;

updating, by said microprocessor, the vector with said first and second sets of data; and

monitoring, by said microprocessor, vector values to determine whether the sensor has lost sensitivity based on a combined vector value of said combination of EIS-based and non-EIS-based parameters crossing said combined threshold value,

wherein sensor glucose values are blinded to a user of the sensor by the microprocessor based on the determination that the sensor has lost sensitivity.

2. The method of claim 1 , wherein said one or more EIS-based parameters include double layer capacitance (Cdl).

3. The method of claim 1 , wherein said one or more non-EIS-based parameters include a period of time during which Isig is low.

4. The method of claim 1 , further including periodically updating the vector values for each of said non-EIS-based parameters.

5. The method of claim 4 , wherein said determination of sensitivity loss is made based on comparison of one of the vector values to a corresponding threshold value.

6. The method of claim 4 , wherein the sensor is determined to have lost sensitivity when a plurality of the vector values have crossed their corresponding threshold values.

7. The method of claim 6 , wherein said plurality of vector values include values for at least one EIS-based parameter and at least one non-EIS-based parameter.

8. The method of claim 1 , wherein each of said threshold values is an absolute threshold value.

9. The method of claim 1 , wherein each of said threshold values is a relative threshold value.

10. The method of claim 1 , further including applying a weighting factor to each of the vector values to generate weighted vector values, and determining sensitivity loss based on said weighted vector values.

11. The method of claim 10 , wherein said weighting factor is different for each of the EIS-based parameters and for each of the non-EIS-based parameters.

12. The method of claim 11 , wherein, for each said EIS-based parameter and each said non-EIS-based parameter, a respective weighting factor is calculated based on each parameter's said respective threshold value.

13. The method of claim 1 , wherein said combined threshold value is an absolute threshold value.

14. The method of claim 1 , wherein said combined threshold value is a relative threshold value.

15. The method of claim 1 , wherein said one or more EIS-based parameters include membrane resistance (Rmem).

16. The method of claim 1 , wherein said one or more EIS-based parameters include membrane capacitance (Cmem).

17. The method of claim 1 , wherein said one or more non-EIS-based parameters include variability in sensor current (Isig).

18. The method of claim 1 , wherein said one or more non-EIS-based parameters include rate of change of Isig.

19. A method of performing diagnostics on a subcutaneous or implanted glucose sensor having at least one working electrode, comprising:

defining a vector containing values associated with one or more electrochemical impedance spectroscopy (EIS)-based parameters and values associated with one or more non-EIS-based parameters;

defining a combined threshold value for a combination of said EIS-based parameters and said non-EIS-based parameters;

performing, by a microprocessor, a first EIS procedure to generate a first set of data for said values associated with the one or more EIS-based parameters;

after a calculated time interval, performing, by said microprocessor, a second EIS procedure to generate a second set of data for said values associated with the one or more EIS-based parameters;

updating, by said microprocessor, the vector with said first and second sets of data;

monitoring, by said microprocessor, vector values to determine whether the sensor has lost sensitivity based on a combined vector value of said combination of EIS-based and non-EIS-based parameters crossing said combined threshold value; and

terminating said glucose sensor by the microprocessor based on the determination that the sensor has lost sensitivity.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: VARSAVSKY, ANDREA; YU, FEI; YANG, NING
To: MEDTRONIC MINIMED, INC.
Reel/Frame 034179/0758 →
Cited By (2)
US 12,295,711 US 12,507,921